Tigecycline for treatment of carbapenem-resistant klebsiella pneumoniae infections after liver transplantation in the intensive care unit: A 3-year study

Transplantation Proceedings

Volumn 46, Issue 9, 2014, Pages 3219-3221

  Mouloudi, E ^a   Massa, E ^a   Piperidou, M ^a   Papadopoulos, S ^a   Iosifidis, E ^a   Roilides, I ^a   Theodoridou, T ^a   Kydona, C ^a   Fouzas, I ^a   Imvrios, G ^a   Papanikolaou, V ^a   Gritsi Gerogianni, N ^a  

^a Intensive Care Unit Hippokratio University Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; COLISTIN; GENTAMICIN; TIGECYCLINE; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; MINOCYCLINE;

ABDOMINAL INFECTION; ADULT; ANTIBIOTIC SENSITIVITY; APACHE; BLOODSTREAM INFECTION; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE INFECTION; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG EFFICACY; DRUG TOLERANCE; DRUG TREATMENT FAILURE; FEMALE; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE INFECTION; LENGTH OF STAY; LIVER DYSFUNCTION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MONOTHERAPY; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; PILOT STUDY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SUPERINFECTION; SURGICAL INFECTION; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA; ADOLESCENT; AGED; ANALOGS AND DERIVATIVES; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; FOLLOW UP; GREECE; INCIDENCE; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIOLOGY; RISK FACTOR; TIME; TREATMENT OUTCOME; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; FEMALE; FOLLOW-UP STUDIES; GREECE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MINOCYCLINE; PILOT PROJECTS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84927674586     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2014.09.160     Document Type: Conference Paper

References (11)

1. Tzouvelekis LS, Markogiannakis A, Psichogiou M., Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 2012; 25:682-707.
2. Falagas ME, Lourida P, Poulikakos P., Rafailidis PI, Tansarli GS. Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother 2014; 58(2):654-63.
3. Pankey GA. Tigecycline. J Antimicrob Chemother 2005; 56: 470-80.
4. Bodmann KF, Heizmann WR, von Eiff C, Petrik C, Löschmann PA, Eckmann C. Therapy of 1,025 severely ill patients with complicated infections in a German multicenter study: safety profile and efficacy of tigecycline in different treatment modalities. Chemotherapy 2012; 58:282-94.
5. Mouloudi E, Protonotariou E, Zagorianou A., Iosifidis E, Karapanagiotou A, Giasnetsova T., et al. Bloodstream infections caused by metallo-b-lactamase/Klebsiella pneumoniae carbapenemasee producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes. Infect Control Hosp Epidemiol 2010; 31:1250-6.
6. Patel G, Huprikar S, Factor S.H., Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008; 29:1099-106.
7. Lübbert C., Becker-Rux D, Rodloff A.C., Laudi S., Busch T, Bartels M, Kaisers UX Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case-control analysis. Infection 2014 Apr; 42(2):309-16.
8. Bergamasco MD, Barroso Barbosa M, de Oliveira Garcia D, Cipullo R, Moreira JC, Baia C, et al. Infection with Klebsiella pneumoniae carbapenemase (KPC) eproducing K. pneumoniae in solid organ transplantation. Transpl Infect Dis 2012; 14:198-205.
9. Kalpoe JS, Sonnenberg E, Factor S.H., del Rio Martin J, Schiano T, Patel G, Huprikar S. Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl 2012; 18:468-74.
10. Gardiner D, Dukart G, Cooper A., Babinchak T. Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials. Clin Infect Dis 2010; 50:229-38.
11. Guner R, Hasanoglu I, Keske S., Kalem AK, Tasyaran MA. Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy. Infection 2011; 39:515-8.